CorMedix
CRMD
#7170
Rank
A$0.92 B
Marketcap
A$11.89
Share price
-0.35%
Change (1 day)
-43.75%
Change (1 year)

Earnings for CorMedix (CRMD)

Earnings in 2026 (TTM): A$0.27 Billion

According to CorMedix's latest financial reports the company's current earnings are A$0.40 Billion. In 2025 the company made an earning of A$0.20 Billion, an increase over its 2024 earnings that were of -A$26.94 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for CorMedix from 2009 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) A$0.27 B31.58%
2025 A$0.20 B-876.29%
2024 -A$26.94 Million-58.3%
2023 -A$64.6 Million53%
2022 -A$42.22 Million2.81%
2021 -A$41.07 Million8.32%
2020 -A$37.92 Million26.53%
2019 -A$29.97 Million-19.89%
2018 -A$37.4 Million-18.72%
2017 -A$46.02 Million34.56%
2016 -A$34.2 Million34.88%
2015 -A$25.36 Million-11.08%
2014 -A$28.52 Million124.69%
2013 -A$12.69 Million144.91%
2012 -A$5.19 Million-48.41%
2011 -A$10.05 Million-33.29%
2010 -A$15.06 Million78.42%
2009 -A$8.44 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Becton Dickinson
BDX
A$2.29 B 789.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Utah Medical Products
UTMD
A$18.72 M-92.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
A$82.37 M-68.06%๐Ÿ‡บ๐Ÿ‡ธ USA